Subscribe
Subscribe for the Newsletter
Mobile Navigation
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Experience
Market Research
Directory
Close
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Grand River Has Come a Long Way
N
Nice Insight
Apr 12, 2017
PTV-M11-16-AP-026
CDMO
Biologics - Large Molecule
PA TV (video)
Tom Ross, President and CEO, Grand River
Related Content
Perfusion
From Fed-Batch to Continuous Processes: How Perfusion Enables Smarter Biologics Production
Seohyeon Song
Samsung Biologics
PAO-10-26-CL-07
Nov 16, 2026
PAMCPs
Post-Approval Change Management and the Promise of ICH Q12
Pharma's Almanac
PAO-11-26-PA-07
Nov 11, 2026
Biologics CDMO
What Drug Developers Should Look for in a Long-Term Biologics Manufacturing Partner
Angelika Rublack
IDT Biologika
PAO-10-26-CL-11
Nov 10, 2026
Fed-Batch
Advancing S-Tensify™ Through Cell-Line-Specific Process Optimization
Minyong Eom; Hakyung Kim; Dongyoung Park; Sojeong Lee, Ph.D.; Daegyun Lee
Samsung Biologics
PAO-10-26-CL-12
Nov 5, 2026
Analytical Strategy
Analytical Strategy as a Competitive Advantage in Biologics Development
Dr. Dietmar Mayer
IDT Biologika
PAO-10-26-CL-10
Nov 5, 2026
Pharma 4.0
The Business Case for Pharma 4.0: Measuring the Return on Digital Investment
David Alvaro, Ph.D.
Pharma's Almanac
PAO-11-26-PA-03
Nov 4, 2026
Digitalization
The Digital Divide Between Drug Substance and Drug Product Manufacturing
Pharma's Almanac
PAO-11-26-PA-02
Nov 3, 2026
Sustainability
How is sustainability shifting from a reporting exercise to a design constraint in manufacturing and development?
Pharma's Almanac
PAO-10-26-RT-01
Oct 30, 2026
Antibody Data
Does Antibody Development Have a Data Problem?
Sophie Lutter, Ph.D.
Lab Thread
PAO-10-26-CL-08
Oct 26, 2026
Cell Therapy
Overcoming Formulation and Fill/Finish Challenges for Cell Therapies
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-10-26-PA-15
Oct 26, 2026
Orthogonal Methods
Orthogonal Analytics: How Much Characterization Is Enough?
David Alvaro, Ph.D.
Pharma's Almanac
PAO-10-26-PA-14
Oct 22, 2026
SmartScale
Phase-Appropriate CMC Requires a New Phase-Appropriate Manufacturing Model
Jesse McCool, Ph.D.
GBI Biomanufacturing
PAO-10-26-CL-05
Oct 21, 2026
Previous slide
Next slide